Navigation Links
China Medical Technologies Reports Second Fiscal Quarter Financial Results
Date:11/19/2009

,350) (10,306) Retained earnings(1) 1,094,613 1,028,540 884,671 129,599 Total shareholders' equity 1,844,583 1,926,270 1,802,530 264,060 Total liabilities and shareholders' equity 5,783,176 5,780,396 5,452,443 798,752 Note: (1) As a result of the adoption of new authoritative guidance changing the accounting for convertible instruments that can be settled in cash or partially in cash upon conversion, the Company adjusted relevant numbers in the condensed consolidated balance sheet as of March 31, 2009 retrospectively in accordance with GAAP. China Medical Technologies, Inc. Unaudited Condensed Consolidated Statements of Income For the Three Months Ended September 30, 2008 June 30, 2009 September 30, 2009 RMB RMB RMB US$ As As previously adjusted reported (3) (in thousands except for per ADS information) Revenues(1) 193,967 193,967 208,957 166,066 24,328 Cost of revenues (57,308) (57,308) (55,413) (57,517) (8,426) Gross profit 136,659 136,659 153,544 108,549 15,902 Operating expenses: Research and development (6,338) (6,338) (11,703) (9,500) (1,392) Sales and marketing (11,250) (11,250) (10,870) (17,432) (2,554) General and Administrative (25,472) (25,472) (46,954) (45,130) (6,611) Amortization of SPR intangible assets -- -- (27,352) (27,357) (4,008) Total operating expenses (43,060) (43,060) (96,879) (99,419) (14,565) Operating income 93,599 93,599 56,665 9,130 1,
'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009
2. Jiangbo Pharmaceuticals to Present at Brean Murray, Carret 2009 China Growth Conference
3. Novartis to Acquire Majority Stake in Hard to Treat Diseases (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million
4. Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin
5. HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
6. China Nepstar Enters Into Strategic Cooperation Agreement with ATMU to Install More Than 1,000 ATMs in Nepstar Stores
7. China Medical Technologies to Announce Unaudited Financial Results for the Second Fiscal Quarter Ended September 30, 2009 on November 19, 2009
8. China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 2009
9. Perot Systems Announces Strategic Alliance With China Telecom
10. China Medicine Corporations Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan
11. Niusule Launches Niusule Gummy Bears in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Legislation passed in 2003 to slow the spiraling ... to treat Medicare patients has had no meaningful impact ... researchers in the Journal of Clinical Oncology ... outpatient chemotherapy to treat colorectal and lung cancers, and ... prescribe those drugs following the implementation of the recent ...
(Date:9/30/2014)... 30, 2014 Research by UC Irvine immunologists reveals ... light on a vital process that determines how the ... online version of Nature Immunology , neurology professor ... Institute for Immunology colleagues describe a critical mechanism underlying ... the bloodstream. , A T cell is a type ...
(Date:9/30/2014)... 30, 2014 Fat Burning Kitchen , ... best-selling author Mike Geary that is helping people learn the ... into a fat-burning machine in less than 24 hours has ... , “In our culture that is becoming so obsessed ... decipher what is really fact and fiction when it comes ...
(Date:9/30/2014)... White Plains, NY (PRWEB) September 30, 2014 ... (HPCW) recently hosted its annual “In Celebration” gala, ... furthering the nonprofit’s mission of striving to provide ... individuals and families facing a serious or life-limiting ... Westchester Country Club in Rye, NY and recognized ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Two revolutionary procedures ... treatment of gum disease a far less painful ... past. , “If you’ve ever felt electric shock waves surge ... sip a cold beverage, it’s possible you already know the ... who is a general dentist in West Palm Beach, and ...
Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:UCI study uncovers important process for immune system development 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3
... PHILADELPHIA, May 15 The Mobile Massage Team ( ... services for corporate wellness programs, promotional events, and special affairs, ... the 7th Annual Yoga Unites(R) for Living Beyond Breast Cancer ... May 17, from 8:00 a.m. to 12:00 p.m. on the ...
... Paul Capital Healthcare today announced that New York-based partner, ... forms of financing at the 2009 BIO International Convention. ... non-dilutive financing options that can meet the needs of ... and Other Non-traditional Forms of Financing," is scheduled for ...
... PTN ) announced today results for its third quarter ... million, or $0.00 per basic and diluted share, for the quarter ... million, or $0.06 per basic and diluted share, for the same ... 31, 2009 were $5.2 million, compared to $0.7 million for the ...
... Researchers at Intermountain Medical Center in Salt Lake City ... atrial fibrillation, a fairly common heart rhythm disorder, and ... , In a study presented Friday, May 15, at ... Heart Rhythm Society in Boston, researchers unveiled findings from ...
... (NYSE Amex:, SVA ), a leading developer and provider of vaccines ... March 31, 2009. , , Recent Highlights, ... sole provider of, approximately $12.8 million ... inactivated hepatitis A vaccine, Healive, to China,s Ministry of Public, ...
... - U.S. and international thought leaders featured -SAN FRANCISCO, ... trusted resource for clinical trial management systems, this week ... institutions and industry partners at its annual meeting in ... to discuss a variety of initiatives and to hear ...
Cached Medicine News:Health News:Paul Capital Healthcare to Participate in Panel on Non-Traditional Forms of Financing 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 4Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 5Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 6Health News:Study makes first connection between heart disorder and Alzheimer's disease 2Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 2Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 3Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 4Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 5Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 6Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 7Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 8Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 9Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 10Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 11Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 12Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 13Health News:Top Academic Medical Centers, Research Institutions, Partners Gather, Share Experiences, Success Stories at Velos Annual Meeting 2Health News:Top Academic Medical Centers, Research Institutions, Partners Gather, Share Experiences, Success Stories at Velos Annual Meeting 3
(Date:9/30/2014)... 30, 2014 Aileron Therapeutics, Inc. - ... Global Markets Direct,s, ,Aileron Therapeutics, Inc. - Product ... the Aileron Therapeutics, Inc.,s pharmaceutical research and development ... the current therapeutic developmental pipeline of Aileron Therapeutics, ... therapeutics assessment by drug target, mechanism of action ...
(Date:9/30/2014)... ATLANTA , Sept. 30, 2014  Alimera Sciences, ... company that specializes in the research, development and commercialization ... received a $25 million advance from Hercules Technology Growth ... payment is the second and final advance under the ... United Kingdom , Alimera Sciences Limited, ...
(Date:9/30/2014)... , N.J. and NEW BRUNSWICK, N.J., Sept. 30, 2014 ... agreement that allows Kessler Foundation and New Jersey ... biomedical research, education and patient care programs has ... and chief executive officer of Kessler Foundation and ... Jersey Health Foundation. "The experience of ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2
... JERUSALEM, October 20 Oramed Pharmaceuticals,Inc. (OTCBB: ORMP.OB; ... today that its poster entitled "A novel GLP-1,analog delivered ... been accepted for presentation at the Diabetes Technology,Society,s Ninth ... , "The selection of Oramed ...
... Oct. 20 Aethlon Medical, Inc. (OTC Bulletin Board: ... Aethlon Hemopurifier® is effective in capturing the current pandemic ... is the first-in-class medical device able to selectively remove ... During invitro studies, the Hemopurifier® removed 68% ...
Cached Medicine Technology:Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Society's Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA) 2Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus 2Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus 3
Comprehensive and structured clinical resource with access to more than 1,000 medical and surgical conditions, fully indexed with more than 7,500 items and medications....
Athouritative, on the spot answers for acute care and consultations....
... The SphygmoCor Mx Central Blood Pressure ... the SphygmoCor Px system by providing ... pressure waveform., ,Key cardiovascular parameters are ... These parameters include:, Central Systolic, ...
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
Medicine Products: